Citations

Institution: Mayo Clinic Clear

Showing 10 of 108119 citations.

A Sequence-Based Variation Map of Zebrafish
Patowary, Ashok , Purkanti, Ramya , Singh, Meghna , Chauhan, Rajendra , Singh, Angom Ramcharan, Swarnkar, Mohit Kumar , Torroja, Carlos , Kocher, Jean‐Pierre , Clark, Karl J. , Klee, Eric W. , Ekker, Stephen C. , Scaria, Vinod , Sivasubbu, Sridhar , Singh, Naresh , Pandey, Vikas , Clark, Matthew D. , Stemple, Derek L. , Ekker, Stephen C , Clark, Karl J

Zebrafish | April 16, 2013 | Volume: 10 | Issue: 1 | Pages: 15-20

10.1089/zeb.2012.0848 | PMID 23590399 Get It

Abstract Zebrafish ( Danio rerio ) is a popular vertebrate model organism largely deployed using outbred laboratory animals. The nonisogenic nature of the zebrafish as a model system offers the opportunity to understand natural variations and their effect in modulating phenotype. In an effort to better characterize the range of natural variation in this model system and to complement the zebrafish reference genome project, the whole genome sequence of a wild zebrafish at 39-fold genome coverage was determined. Comparative analysis with the zebrafish reference genome revealed approximately 5.2 million single nucleotide variations and over 1.6 million insertion–deletion variations. This dataset thus represents a new catalog of genetic variations in the zebrafish genome. Further analysis revealed selective enrichment for variations in genes involved in immune function and response to the environment, suggesting genome-level adaptations to environmental niches. We also show that human disease gene orthologs in the sequenced wild zebrafish genome show a lower ratio of nonsynonymous to synonymous single nucleotide variations.
Impact of Statin Use on Lipid Levels in Statin‐Naive Patients With Rheumatoid Arthritis Versus Non–Rheumatoid Arthritis Subjects: Results From a Population‐Based Study
Myasoedova, Elena , Gabriel, Sherine E., Green, Abigail B., Matteson, Eric L. , Crowson, Cynthia S. , Myasoedova, Elena

Arthritis Care & Research | April 16, 2013 | Volume: 65 | Issue: 10 | Pages: 1592-1599

10.1002/acr.22029 | PMID 23592565 Get It

ObjectiveTo examine lipid profiles among statin‐naive patients with rheumatoid arthritis (RA) and those without RA before and after the initiation of statins.MethodsInformation regarding lipid measures and statin use was gathered in a population‐based incident cohort of patients with RA (1987 American College of Rheumatology criteria first met between January 1, 1988 and January 1, 2008) and in a cohort of non‐RA subjects from the same underlying population. Only patients with no prior history of statin use were included.ResultsThe study included 161 patients with RA (mean age 56.3 years, 57% female) and 221 non‐RA subjects (mean age 56.0 years, 66% female). Prior to the start of statins, the levels of total cholesterol and low‐density lipoprotein (LDL) cholesterol were lower in the RA versus the non‐RA cohort (P < 0.001 and P = 0.003, respectively). The absolute and percentage change in LDL cholesterol after at least 90 days of statin use tended to be smaller in the RA versus the non‐RA cohort (P = 0.03 and P = 0.09, respectively). After at least 90 days of statin use, patients with RA were less likely to achieve therapeutic goals for LDL cholesterol than the non‐RA subjects (P = 0.046). Increased erythrocyte sedimentation rate (ESR) at baseline (odds ratio 0.47, 95% confidence interval 0.26–0.85) was associated with lower likelihood of achieving therapeutic LDL goals.ConclusionPatients with RA had lower total cholesterol and LDL cholesterol levels before statin initiation and lower likelihood of achieving therapeutic LDL goals following statin use than the non‐RA subjects. Some RA disease characteristics, in particular ESR at baseline, may have an adverse impact on achieving therapeutic LDL goals.
Faculty Opinions recommendation of Loss of transfusion dependency following deferasirox treatment of iron overload in a woman with myelofibrosis and spherocytosis - a case report.
Mesa, Ruben A.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | April 16, 2013 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.717997067.793474168 Get It

Minimally invasive surgical techniques for pancreatic cancer: ready for prime time?
Mesleh, Marc G., Stauffer, John , Asbun, Horacio J. , A Stauffer, John

Journal of Hepato-Biliary-Pancreatic Sciences | April 16, 2013 | Volume: 20 | Issue: 6 | Pages: 578-582

10.1007/s00534-013-0614-2 | PMID 23591745 Get It

AbstractBackgroundMinimally invasive surgical techniques for pancreatic cancer are being applied with increasing frequency. With support of the literature, the location of the tumor within the pancreas is the factor which determines if these techniques can be safely used routinely by pancreatic surgeons.MethodsLiterature supporting minimally invasive techniques for all types of resections for pancreatic cancer was reviewed.ResultsMultiple meta‐analysis regarding laparoscopic distal pancreatectomy all support the routine use of laparoscopy for these lesions. There are several case series describing the safety and efficacious use of laparoscopy in pancreaticoduodenectomy, and results have been promising in these highly specialized centers.ConclusionsThe location of the tumor within the pancreas remains the most critical factor in the use of laparoscopy as the standard of care. Lesions in the body and tail, which are readily resected with a distal or subtotal pancreatectomy should be performed laparoscopically unless there is a clear reason why not to do so. Lesions in the head of the pancreas have been shown to be removed safely and effectively with laparoscopy. However, the technical skills necessary and the ability to teach these to trainees are the limiting factors to widespread use. Further series are necessary to assess if the laparoscopic approach to pancreaticoduodenectomy will play a similar role as the one it plays in the surgical treatment for distal lesions.
Precision Oncology: An Overview
Garraway, Levi A. , Verweij, Jaap, Ballman, Karla V.

Journal of Clinical Oncology | April 15, 2013 | Volume: 31 | Issue: 15 | Pages: 1803-1805

10.1200/jco.2013.49.4799 | PMID 23589545 Get It

Efatutazone, an Oral PPAR-γ Agonist, in Combination With Paclitaxel in Anaplastic Thyroid Cancer: Results of a Multicenter Phase 1 Trial
Smallridge, Robert C., Copland, John A. , Brose, Marcia S. , Wadsworth, J. Trad , Houvras, Yariv , Menefee, Michael E., Bible, Keith C. , Shah, Manisha H. , Gramza, Ann W., Klopper, Joshua , Marlow, Laura A. , Roemeling, Reinhard von, Heckman, Michael G. , Marlow, Laura

The Journal of Clinical Endocrinology & Metabolism | April 15, 2013 | Volume: 98 | Issue: 6 | Pages: 2392-2400

10.1210/jc.2013-1106 | PMID 23589525 Get It

Improved Resident Physician Confidence With Advance Care Planning After an Ambulatory Clinic Intervention
Tung, Ericka E. , Verdoorn, Brandon P. , Mauck, Karen F. , Post, Jason , Thomas, Matthew R. , Bundrick, John B., Jaeger, Thomas M. , Cha, Stephen S., Thomas, Kris G., Wieland, Mark L. , Cha, Stephen S.

American Journal of Hospice and Palliative Medicine® | April 15, 2013 | Volume: 31 | Issue: 3 | Pages: 275-280

10.1177/1049909113485636 | PMID 23588577 Get It

Many primary care providers feel uncomfortable discussing end-of-life care. The aim of this intervention was to assess internal medicine residents’ advance care planning (ACP) practices and improve residents’ ACP confidence. Residents participated in a facilitated ACP quality improvement workshop, which included an interactive presentation and chart audit of their own patients. Pre- and postintervention surveys assessed resident ACP-related confidence. Only 24% of the audited patients had an advance directive (AD), and 28% of the ACP-documentation was of no clinical utility. Terminally ill patients (odds ratio 2.8, P < .001) were more likely to have an AD. Patients requiring an interpreter were less likely to have participated in ACP. Residents reported significantly improved confidence with ACP and identified important training gaps. Future studies examining the impact on ACP quality are needed.
Oxytocin and vasopressin
Benarroch, Eduardo E.

Neurology | April 15, 2013 | Volume: 80 | Issue: 16 | Pages: 1521-1528

10.1212/wnl.0b013e31828cfb15 | PMID 23589638 Get It

Favorable Stage Distribution in the NELSON Trial
Midthun, David E. , Gould, Michael K.

American Journal of Respiratory and Critical Care Medicine | April 15, 2013 | Volume: 187 | Issue: 8 | Pages: 792-793

10.1164/rccm.201302-0314ed | PMID 23586379 Get It

Management of unruptured intracranial aneurysms
Williams, Lindsy N., Brown, Robert D.

Neurology Clinical Practice | April 15, 2013 | Volume: 3 | Issue: 2 | Pages: 99-108

10.1212/cpj.0b013e31828d9f6b | PMID 23914319 Get It